Management of patients with acute nonspecific low back pain
https://doi.org/10.14412/2074-2711-2015-2-52-55
Abstract
The paper describes an observation of a female patient with acute non-specific low back pain (LBP). It gives current recommendations for the
treatment of acute LBP and evaluates the clinical efficiency of these methods. The management of patients with acute nonspecific LBP encompasses: 1) correct information about the nature and prognosis of the disease; 2) recommendations for daily activities; 3) a short-term rational therapy with paracetamol, nonsteroidal anti-inflammatory drugs (NSAIDs), and/or myorelaxants. The role of NSAIDs, ketorol in particular, in treating patients with acute nonspecific LBP is discussed.
About the Authors
A. I. Isaikin
Department of Nervous System Diseases and Neurosurgery, Faculty of Therapeutics, I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia, Moscow, Russia 11, Rossolimo St., Moscow 119021
Russian Federation
Russian Federation
V. A. Golovacheva
Department of Nervous System Diseases and Neurosurgery, Faculty of Therapeutics, I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia, Moscow, Russia 11, Rossolimo St., Moscow 119021
Russian Federation
Russian Federation
I. V. Kuznetsov
Department of Nervous System Diseases and Neurosurgery, Faculty of Therapeutics, I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia, Moscow, Russia 11, Rossolimo St., Moscow 119021
Russian Federation
Russian Federation
References
1. Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 disease and injuries 1990–2010: a systematic analysis for Global Burden of Disease Study 2010. Lancet. 2012 Dec 15;380(9859):2163–96. doi: 10.1016/S0140-6736(12)61729-2.
2. Airaksinen O, Brox JI, Cedraschi C, et al. European guidelines for the management of chronic nonspecific low back pain. Eur Spine J. 2006 Mar;15 Suppl 2:S192–300.
3. Henschke N, Maher CG, Refshauge KM, et al. Prognosis in patients with recent onset low back pain in Australian primary care: inception cohort study. BMJ. 2008 Jul 7;337:a171. doi: 10.1136/bmj.a171.
4. Wenig CM, Schmidt CO, Kohlmann T, Schweikert B. Cost of back pain in Germany. Eur J Pain. 2009 Mar;13(3):280–6. doi: 10.1016/j.ejpain.2008.04.005. Epub 2008 Jun 3.
5. Парфенов ВА. Мышечный спазм при боли в спине – патогенез, диагностика и лечение. Русский медицинский журнал. 2003;(10);590–4. [Parfenov VA. Muscle spasm in ack pain – pathogenesis, diagnosis and treatment. Russkii meditsinskii zhurnal. 2003;(10);590–4. (In Russ.)].
6. Парфенов ВА, Яхно НН, Дамулин ИВ. Нервные болезни. Частная неврология и нейрохирургия. Москва: МИА; 2014. 280 с. [Parfenov VA, Yakhno NN, Damulin IV. Nervnye bolezni. Chastnaya nevrologiya i neirokhirurgiya [Nervous diseases. Partial neurology and neurosurgery]. Moscow: MIA; 2014. 280 p.]
7. Парфенов ВА. Причины, диагностика и лечение боли в нижней части спины. Неврология, нейропсихиатрия, психосоматика. 2009;1(1):19–22. [Parfenov VA. Low back pain: causes, diagnosis, and treatment. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2009;1(1):19–22. (In Russ.)]. DOI: http://dx.doi.org/10.14412/2074-2711-2009-17
8. Парфенов ВА. Диагноз и лечение при болях в спине. Русский медицинский журнал. 2004;(2):115–20. [Parfenov VA. Diagnosis and treatment for back pain. Russkii meditsinskii zhurnal. 2004;(2):115–20. (In Russ.)].
9. Подчуфарова ЕВ, Яхно НН. Боль в спине. Москва: ГЭОТАР-Медиа; 2010. 368 с. [Podchufarova EV, Yakhno NN. Bol' v spine [Back pain]. Moscow: GEOTAR-Media; 2010. 368 p.]
10. Chou R, Shekelle P. Will this patient develop persistent disablinglow back pain? JAMA. 2010 Apr 7;303(13):1295–302. doi: 10.1001/jama.2010.344.
11. van Tulder MW, Becker A, Bekkering T, et al. European guidelines for the management of acute nonspecific low back pain in primary care. Eur Spine J. 2006 Mar;15 Suppl 2:S169–91.
12. Roelofs PD, Deyo RA, Koes BW, et al. Non-steroidal anti-inflammatory drugs for low back pain. Cochrane Database Syst Rev. 2008 Jan 23;(1):CD000396. doi: 10.1002/14651858.CD000396.pub3.
13. Forrest JB, Camu F, Greer IA, et al. Ketorolac, diclofenac, and ketoprofen are equally safe for pain relief after major surgery. Br J Anaesth. 2002 Feb;88(2):227–33.
14. Veenema KR, Leahey N, Schneider S. Ketorolac versus meperidine: ED treatment of severe musculoskeletal low back pain. Am J Emerg Med. 2000 Jul;18(4):404–7.
15. Jelinek GA. Ketorolac versus morphine for severe pain. Ketorolac is more effective, heaper, and has fewer side effects. BMJ. 2000 Nov 18;321(7271):1236–7.
16. Алексеев ВВ. Ступенчатая терапия НПВП острого болевого синдрома в пояснично-крестцовой области. Эффективная фармакотерапия в неврологии и психиатрии. 2010;(4):22–8. [Alekseev VV. Sequential therapy by NSAIDs for acute pain in lumbosacral region. Effektivnaya farmakoterapiya v nevrologii i psikhiatrii. 2010;(4):22–8. (In Russ.)].
17. Верткин АЛ, Тополянский АВ, Вовк ЕИ. Место кеторолака в терапии острых болевых синдромов на догоспитальном этапе. Consilium Medicum. 2006;8(2):86–90. [Vertkin AL, Topolyanskii AV, Vovk EI. Ketorolac in the treatment of acute pain in the prehospital phase. Consilium Medicum. 2006;8(2):86–90. (In Russ.)].
18. Парфенов ВА. Боли в спине и их лечение мидокалмом. Русский медицинский журнал. 2009;(4):267–72. [Parfenov VA. Back pain and their treatment by mydocalm. Russkii meditsinskii zhurnal. 2009;(4):267–72. (In Russ.)].
19. van Tulder MW, Touray T, Furlan AD, et al. Muscle relaxants for non-specific low back pain. Cochrane Database Syst Rev. 2003;(2):CD004252.
20. See S, Ginzburg R. Choosing a skeletal muscle relaxant. Am Fam Physician. 2008 Aug 1;78(3):365–70.
Review
For citations:
Isaikin AI, Golovacheva VA, Kuznetsov IV. Management of patients with acute nonspecific low back pain. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2015;7(2):52-55. (In Russ.) https://doi.org/10.14412/2074-2711-2015-2-52-55
Views:
1046
Email this article 